CTX-M-3 extended-spectrum β-lactamase in a Shigella sonnei clinical isolate: First report from Turkey

Acikgoz Z. C., Gulay Z., Bicmen M., Gocer S., Gamberzade S.

Scandinavian Journal of Infectious Diseases, cilt.35, sa.8, ss.503-505, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 35 Sayı: 8
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1080/00365540310013270
  • Dergi Adı: Scandinavian Journal of Infectious Diseases
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.503-505
  • Lokman Hekim Üniversitesi Adresli: Hayır

Özet

A Shigella sonnei strain resistant to cefotaxime and aztreonam (but not ceftazidime) was isolated from the stool sample of a 7-y-old outpatient. Double disk synergy test, isoelectric focusing, polymerase chain reaction and sequence analysis confirmed that the isolate produced CTX-M-3, an extended-spectrum β-lactamase (ESBL). This is the first report from Turkey of Shigella spp. producing an ESBL, and of CTX-M type enzyme.